These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17548187)

  • 41. Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance.
    Kuti JL; Capitano B; Nicolau DP
    Pharmacoeconomics; 2002; 20(8):513-28. PubMed ID: 12109917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Panton-Valentine Leukocidin associated with community acquired methicillin resistant Staphylococcus aureus: a case report and review of interim guidelines.
    Baldwin LN; Lowe AD
    Anaesthesia; 2008 Jul; 63(7):764-6. PubMed ID: 18582262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chlamydia pneumoniae and Mycoplasma pneumoniae.
    Blasi F; Tarsia P; Aliberti S; Cosentini R; Allegra L
    Semin Respir Crit Care Med; 2005 Dec; 26(6):617-24. PubMed ID: 16388430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mycoplasma pneumoniae and Chlamydophila pneumoniae in children with community-acquired pneumonia in Thailand.
    Lochindarat S; Suwanjutha S; Prapphal N; Chantarojanasiri T; Bunnag T; Deerojanawong J; Kunakorn M; Srisan P
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):814-9. PubMed ID: 17609060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.
    Sahm DF; Brown NP; Thornsberry C; Jones ME
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):16-24. PubMed ID: 18931467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Community-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patients.
    Huang HH; Zhang YY; Xiu QY; Zhou X; Huang SG; Lu Q; Wang DM; Wang F
    Eur J Clin Microbiol Infect Dis; 2006 Jun; 25(6):369-74. PubMed ID: 16767484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Atypical infection of the respiratory tract and bronchial asthma].
    Jahnz-Rózyk K; Targowski T
    Pol Merkur Lekarski; 2007 Nov; 23(137):325-7. PubMed ID: 18361312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Community-acquired pneumonia: what is relevant and what is not?
    Talwar A; Lee H; Fein A
    Curr Opin Pulm Med; 2007 May; 13(3):177-85. PubMed ID: 17414124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Questionnaire survey of guideline implementation for community acquired pneumonia with retrospective analysis of the empiric treatment in 490 patients].
    Xu ZJ; Ding K; Huang H; Sun TY; Ke HX; Tong ZH; Wei TN; Peng K; Yao B; Li FX; Liu JH; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):442-6. PubMed ID: 17673019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 13--Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents.
    Roig J; Casal J; Gispert P; Gea E
    Med Mal Infect; 2006; 36(11-12):680-9. PubMed ID: 17095177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lower respiratory tract infections and community acquired pneumonia in adults.
    Stocks N; Turnidge J; Crockett A
    Aust Fam Physician; 2004 May; 33(5):297-301. PubMed ID: 15227857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in antibiotic therapy for community-acquired pneumonia.
    Viasus D; Garcia-Vidal C; Carratalà J
    Curr Opin Pulm Med; 2013 May; 19(3):209-15. PubMed ID: 23422416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microbial etiologies in community acquired pneumonia (CAP).
    Szmygin-Milanowska K; Kieszko R; Chudnicka A; Milanowski J
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):466-74. PubMed ID: 15315033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones.
    Moran G
    J Emerg Med; 2006 May; 30(4):377-87. PubMed ID: 16740445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology of healthcare-associated pneumonia (HCAP).
    Zilberberg MD; Shorr AF
    Semin Respir Crit Care Med; 2009 Feb; 30(1):10-5. PubMed ID: 19199182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
    Bartlett JG
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Microbiologic diagnosis of community-acquired pneumonia in adults].
    Jiménez P P; Calvo A M
    Rev Chilena Infectol; 2005; 22 Suppl 1():s32-8. PubMed ID: 16163417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Community-Acquired Pneumonia in the Asia-Pacific Region.
    Song JH; Huh K; Chung DR
    Semin Respir Crit Care Med; 2016 Dec; 37(6):839-854. PubMed ID: 27960208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of Mycoplasma and Chlamydia pneumonia in severe community-acquired pneumonia among hospitalized children in Thailand.
    Samransamruajkit R; Jitchaiwat S; Wachirapaes W; Deerojanawong J; Sritippayawan S; Prapphal N
    Jpn J Infect Dis; 2008 Jan; 61(1):36-9. PubMed ID: 18219132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Community-acquired pneumonia in children in Lambarene, Gabon.
    Lassmann B; Poetschke M; Ninteretse B; Issifou S; Winkler S; Kremsner PG; Graninger W; Apfalter P
    Am J Trop Med Hyg; 2008 Jul; 79(1):109-14. PubMed ID: 18606773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.